Buying pressure in the yen lead to a brief dip in the dollar compared to that currency, with David Woo, BofA Merrill Lynch Global Research, and Gary Kozlowski, United Futures Trading. "The only thing that can save the euro is a weaker euro," adds Woo.
Willem Nabarro, Head of European Equities for Asia at Exane-BNP Paribas, says the Cyprus saga is an opportunity to come back to the market.
CNBC's Seema Mody takes a look at how the S&P 500 and the Dow have performed since the lows of March in 2009; and Edward Yardeni of Yardeni Research and Michael Ozanian of Forbes Magazine, weigh in.
Mad Money host Jim Cramer shares his final thoughts of the day.
Non-Executive Chairman of Avon Fred Hassan discusses his new book "Reinvent: A Leader's Playbook for Serial Success."
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
Inventing new drugs can be a fabulous growth business, but biotech stocks represent the future of pharma, explains Mad Money host Jim Cramer. A look at Regeneron Pharmaceuticals.
Paychex president & CEO Marty Mucci shares his economic outlook, and discusses how his company is building customers.
Mad Money host Jim Cramer dissects the market's latest action, and what market events to look out for in the first week of Q2.
Mad Money host and former hedge fund manager, Jim Cramer, provides stock traders with all manner of investing advice.
The Fast Money traders share their final trades of the day.
China is a major part of the weight on emerging market stocks, explains "Fast Money" trader Timothy Seymour. Also, how to play Apple now.
In tonight's "Fast Money Madness," the traders debate whether Google or IBM make a better buy.
What to watch in the defense sector in Q2, with CNBC's Jane Wells; and how to play Home Depot and Best Buy, with the "Fast Money" traders.
The strongest Dow performer in Q1 is Hewlett-Packard. A closer look at the stock, with Brian Marshall, ISI Group.
Pinnacle Foods is up more than 11 percent in its first day of trading, with the "Fast Money" traders; and Ehud Gelblum of Morgan Stanley, shares his strategies to playing BlackBerry. "When gross margins go up in handset companies, stocks work," he says.
The secular challenges for Hewlett-Packard loom large, ISI's Brian Marshall says.
Leaders in stock market gains by health care or consumer staples shouldn't be discounted, Chris Verrone of Strategas says.
An all-time closing high in the S&P 500 wasn't enough to turn Shelter Harbor Capital's Brian Kelly away from his bearish theme.
Dissecting the day's major business news, with the Fast Money traders; and Chris Verrone of Strategas, offers his strategies to playing the market. "I don't buy the argument that health care and staples are bad leadership," explains.